Our live Investing Matters Podcast Special which took place at the Master Investor Show discussing 'How undervalued is the UK stock market?', has just been released. Listen here.
AS and EF have recently awarded themselves a shed load of new options. Thus enables them to benefit from any SP rise whilst not having to risk their own money. The recent raise must have been a strong possibility when these options were announced - just wondering if the performance benchmark is from 50p?
I'll try and help. This tests, which is still only on the bench, tests whether someone has malaria. The avacta test is to determine whether the parasite is drug resistant.
Hope that helps.
Thanks for posting. Did well to find it.
JT makes good point about the dry nature of scientific presentations. It goes along side that nothing is proven without the evidence, the whole evidence and....
The change in language I think (and its only an opinion) is driven by the overhype by MM and the pom pom girls. Anything vaguely positive is immediately translated into a series of absolute facts and pump several times a day. Given the loss some retail investors will now be in the nomad has probably advised not to supply the pump and dump brigade with the ammunition. AS actually called them out last AGM when he took the p 1 55 out of them claiming a cure for cancer.
There are gaps in the data - you can make up stuff to fill the gap depending on whether you ramp or deramp but the gap means the SP will change. One way or the other. Someone claiming they know which way beyond doubt has other motivations than your personal wealth position. In some cases its the exact opposite.
NY what matters is how much is hitting the tumour compared to a dose of normal dox. One way of increasing that is to give more frequent doses. Avacta will know the conversion rate because they are measuring pK of the leaving group. They have chosen not to communicate this to the people who own the company. I suspect potential new owners have seen it.
NY they haven't given 2x the dose of dox. They give ava6000 a % of which is converted to dox. The MOA is that concentrations are very high at site of conversion. See last set of Q and A which confirms it is notb100% conversion.
Probably worried about appearing to be boosting. Think they are going to need a bigger venue for next AGM.
Just seen bloke over on twitter collecting votes for no confidence motion
That's not a bad strategy but you would normally implement it before you spent a shed load of hard to come by cash on two overpriced Dx companies and then fail to leverage your own in-house IP
AS to board last week
Big science presentation at major event in April
Let's accelerate a book build before anyone sees this paradigm shift.
Whilst you are at it I've had ago at Dx for about 20 years and my last effort was truly awful. One day someone might get tested with an affimer they paid for. Until then would you mind reseting my options package.
Where is Mr 7 make it 8 questions when we need him?
Great made up word. Looks like it wasn't true.
Don't worry - again not true
Improve communications. I rest my case
EF do the honourable thing and just go. Hand back all your options and perks cause you haven't earned them. I really don't think we need to go through the whole appraisal, HR, performance appraisal thing do we.
Bump
Why would they buy shares when they award themselves massive option packages. They wouldn't risk their own money when they win massively if it comes off and lose nothing if it doesn't.
Who. How?
There are some large retail share holder groups. I'm happy to lend my vote to anyone who proposes that AS and EF leave Avacta.
Agree. I would also add Elliot F to the P45.
The pair of them have overseen award after award of share options that replace any where they failed to hit the target. This raise was well known before PIs were given the info and I suspect the same group of II were responsible for the sell off as soon as price was agreed in principle last week.
How do we get rid of them
Have cash ready - market can be slow to react whereas PIs can get in at start
Last I heard myles and the pom pom girls were all boasting about how they has a sneaky top up at £1.06.
Genuinely I hope it comes good for them (and me) but not sure why they think continually getting it wrong needs to be broadcasted all over social media. Perhaps tone down the certainty. Hopefully some new inputs for the magic calculator soon.
Suspect AS and EF have either seen sense or it was never going to happen. Little bit of history repeating.
If affyxell float are avacta in for swapping their % for cash ?
Avacta part own affyxell. Affyxell don't own the affimer IP. They have interest in very limited number of affimers.
Avacta could sell their share and raise money. Affyxell get on with proving concept. Avacta then sell more affimers but could lse out on both capital gain and revenue depending on deal for affyxell.
To me makes more sense than selling diagnostics if Dx strategy was sound.